▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for National Research in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $46.85.
The current consensus among 0 polled investment analysts is to n/a stock in National Research. This rating has held steady since February 2020, when it changed from a Hold consensus rating.
National Research Corp. engages in the provision of analytics and insights that facilitate patient, employee, and customer retention. It offers solutions that address specific needs around market insight, experience, transparency, and governance for healthcare providers, payers, and other healthcare organizations. The company was founded by Michael D. Hays in 1981 and is headquartered in Lincoln, NE.